Sign inGet started

Sable Carole

Insider CIK 1604066 · VTAE Chief Medical Officer · SCYX Chief Medical Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
VTAE Vitae Pharmaceuticals, Inc D To issuer deriv2016-10-252016-10-25150,000$10.49 $1.57M0SEC↗
VTAE Vitae Pharmaceuticals, Inc A Award deriv2016-06-062016-06-08150,000— $0150,000SEC↗
SCYX SCYNEXIS INC A Award deriv2014-06-182014-06-2026,970— $026,970SEC↗
SCYX SCYNEXIS INC A Award deriv2014-06-182014-06-2046,636— $046,636SEC↗
SCYX SCYNEXIS INC D To issuer deriv2014-06-182014-06-2046,636— $00SEC↗